Market Cap 912.61M
Revenue (ttm) 0.00
Net Income (ttm) -206.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,662,818
Avg Vol 2,996,582
Day's Range N/A - N/A
Shares Out 163.84M
Stochastic %K 98%
Beta 1.18
Analysts Strong Sell
Price Target $13.55

Company Profile

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. It is also developing ANX007,...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 822 5500
Fax: 650 636 9773
Address:
1400 Sierra Point Parkway, Building C Suite 200, Brisbane, United States
Lightening_strikes
Lightening_strikes Jul. 1 at 3:42 PM
$ANNX lolz What a POS
0 · Reply
Lightening_strikes
Lightening_strikes Jul. 1 at 3:16 PM
$ANNX junk can’t hold
0 · Reply
NewBee13
NewBee13 Jul. 1 at 1:58 PM
$ANNX Top contain broken. Will be going into the 6s. Nice
1 · Reply
makingdoughfromoptions
makingdoughfromoptions Jul. 1 at 1:56 PM
$ANNX The ol market makers having their fun with share price today out the gate. Never, ever buy before 10-10:30. That said, our catalysts await.
0 · Reply
Lightening_strikes
Lightening_strikes Jun. 30 at 12:19 PM
$ANNX there was a GBs presentation in Europe yesterday. Any insights?
0 · Reply
Lightening_strikes
Lightening_strikes Jun. 29 at 11:34 PM
$ANNX guy with 19k shares blocked me, lolz I have multiples of that!
0 · Reply
Sly15
Sly15 Jun. 29 at 2:54 PM
$ANNX Looks like they are re tooling leadership team a bit. Given their execution history I take this as a positive
1 · Reply
Akascottie
Akascottie Jun. 29 at 1:09 PM
$ANNX added to the Russell:)))
2 · Reply
makingdoughfromoptions
makingdoughfromoptions Jun. 29 at 12:24 PM
$ANNX All: Heavy institutional buying, heavy insider buying. The retail float is 15% or so of avail. shares. I suggest we follow these guys, especially when a director who runs a successful biotech investment company backs up the truck on shares. Buy, sit a spell, wait for catalysts. They are coming and ANNX will reprice massively to the better. I own or control via options 19,000 shares.
1 · Reply
NewBee13
NewBee13 Jun. 28 at 12:35 PM
$ANNX Chart hsitory says rejection at 5.60-5.70. A break through would be encouraging for growth. Rejection is just another predictable pattern. Lets see Monday!
2 · Reply
Latest News on ANNX
Annexon Transcript: AGM 2026

Jun 11, 2026, 11:00 AM EDT - 20 days ago

Annexon Transcript: AGM 2026


Annexon Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 11:40 AM EDT - 4 weeks ago

Annexon Transcript: Jefferies Global Healthcare Conference 2026


Annexon to Participate in Upcoming June Investor Conferences

May 27, 2026, 8:00 AM EDT - 5 weeks ago

Annexon to Participate in Upcoming June Investor Conferences


Annexon initiated with a Neutral at Goldman Sachs

2026-05-12T09:15:39.000Z - 7 weeks ago

Annexon initiated with a Neutral at Goldman Sachs


110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS

May 11, 2026, 10:00 AM EDT - 7 weeks ago

110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS


Annexon reports Q1 EPS (23c), consensus (30c)

2026-05-07T21:46:09.000Z - 7 weeks ago

Annexon reports Q1 EPS (23c), consensus (30c)


Annexon Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 7 weeks ago

Annexon Quarterly report: Q1 2026


Annexon Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 7 weeks ago

Annexon Earnings release: Q1 2026


Annexon Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Annexon Proxy statement: Proxy filing


Annexon Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Annexon Proxy statement: Proxy filing


Annexon Slides: Corporate presentation

Apr 27, 2026, 7:00 AM EDT - 2 months ago

Annexon Slides: Corporate presentation


Annexon Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Annexon Proxy statement: Proxy filing


Annexon files automatic mixed securities shelf

2026-03-31T10:20:07.000Z - 3 months ago

Annexon files automatic mixed securities shelf


Annexon reports Q4 EPS (28c), consensus (32c)

2026-03-30T20:18:52.000Z - 3 months ago

Annexon reports Q4 EPS (28c), consensus (32c)


Annexon Earnings release: Q4 2025

Mar 30, 2026, 7:00 AM EDT - 3 months ago

Annexon Earnings release: Q4 2025


Annexon Annual report: Q4 2025

Mar 30, 2026, 7:00 AM EDT - 3 months ago

Annexon Annual report: Q4 2025


Annexon Transcript: KOL event

Mar 18, 2026, 2:00 PM EDT - 3 months ago

Annexon Transcript: KOL event


Annexon Slides: KOL event

Mar 18, 2026, 2:00 PM EDT - 3 months ago

Annexon Slides: KOL event


Annexon Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 9:50 AM EST - 4 months ago

Annexon Transcript: TD Cowen 46th Annual Health Care Conference


Annexon Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 2:15 PM EST - 5 months ago

Annexon Slides: 44th Annual J.P. Morgan Healthcare Conference


Annexon highlights its 2026 strategic priorities

2026-01-12T12:39:27.000Z - 6 months ago

Annexon highlights its 2026 strategic priorities


Annexon submits MAA to EMA for tanruprubart

2026-01-08T13:05:13.000Z - 6 months ago

Annexon submits MAA to EMA for tanruprubart


Annexon initiated with a Buy at Chardan

2025-12-23T09:35:20.000Z - 6 months ago

Annexon initiated with a Buy at Chardan


Annexon initiated with a Buy at Clear Street

2025-12-01T21:20:32.000Z - 7 months ago

Annexon initiated with a Buy at Clear Street


Annexon price target raised to $27 from $14 at Wells Fargo

2025-11-19T11:35:39.000Z - 8 months ago

Annexon price target raised to $27 from $14 at Wells Fargo


Annexon Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 3:30 AM EST - 8 months ago

Annexon Transcript: Jefferies London Healthcare Conference 2025


Annexon price target lowered to $8 from $9 at BofA

2025-11-17T14:30:07.000Z - 8 months ago

Annexon price target lowered to $8 from $9 at BofA


Annexon price target lowered to $8 from $9 at BofA

2025-11-16T15:55:10.000Z - 8 months ago

Annexon price target lowered to $8 from $9 at BofA


Annexon 25.1M share Spot Secondary priced at $2.60

2025-11-13T04:25:17.000Z - 8 months ago

Annexon 25.1M share Spot Secondary priced at $2.60


Annexon announces $75M common stock, warrants offering

2025-11-12T21:23:07.000Z - 8 months ago

Annexon announces $75M common stock, warrants offering


Annexon reports Q3 EPS (37c), consensus (34c)

2025-11-10T21:40:18.000Z - 8 months ago

Annexon reports Q3 EPS (37c), consensus (34c)


Annexon Earnings release: Q3 2025

Nov 10, 2025, 7:00 AM EST - 8 months ago

Annexon Earnings release: Q3 2025


Annexon Quarterly report: Q3 2025

Nov 10, 2025, 7:00 AM EST - 8 months ago

Annexon Quarterly report: Q3 2025


Annexon participates in a conference call with JPMorgan

2025-09-15T14:40:07.000Z - 10 months ago

Annexon participates in a conference call with JPMorgan


Annexon Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 10 months ago

Annexon Transcript: Cantor Global Healthcare Conference 2025


Annexon reports Q2 EPS (34c), consensus (36c)

2025-08-14T20:36:16.000Z - 11 months ago

Annexon reports Q2 EPS (34c), consensus (36c)


Annexon reports Q2 EPS (34c), consensus (36c)

2025-08-14T20:15:45.000Z - 11 months ago

Annexon reports Q2 EPS (34c), consensus (36c)


Annexon Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

Annexon Earnings release: Q2 2025


Annexon Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

Annexon Quarterly report: Q2 2025


Annexon completes enrollment in Phase 3 ARCHER II trial

2025-07-24T11:15:36.000Z - 1 year ago

Annexon completes enrollment in Phase 3 ARCHER II trial


Annexon tells Wells Fargo doctor tweet not factural

2025-07-10T17:50:08.000Z - 1 year ago

Annexon tells Wells Fargo doctor tweet not factural


Annexon Earnings release: Q1 2025

May 12, 2025, 12:30 PM EDT - 1 year ago

Annexon Earnings release: Q1 2025


Annexon Quarterly report: Q1 2025

May 12, 2025, 12:30 PM EDT - 1 year ago

Annexon Quarterly report: Q1 2025


Annexon Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Annexon Proxy statement: Proxy Filing


Annexon Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Annexon Proxy statement: Proxy Filing


Annexon Annual report: Q4 2024

Mar 3, 2025, 12:00 AM EST - 1 year ago

Annexon Annual report: Q4 2024


Annexon Slides: FY 2025

Jan 14, 2025, 6:00 PM EST - 1 year ago

Annexon Slides: FY 2025


Annexon Transcript: Study Result

Dec 16, 2024, 8:30 AM EST - 1 year ago

Annexon Transcript: Study Result


Annexon Press release: Study Result

Dec 16, 2024, 8:30 AM EST - 1 year ago

Annexon Press release: Study Result


Annexon Slides: Study Result

Dec 16, 2024, 8:30 AM EST - 1 year ago

Annexon Slides: Study Result


Annexon Quarterly report: Q3 2024

Nov 14, 2024, 9:30 AM EST - 1 year ago

Annexon Quarterly report: Q3 2024


Annexon Transcript: 2024 Wells Fargo Healthcare Conference

Sep 4, 2024, 9:30 AM EDT - 1 year ago

Annexon Transcript: 2024 Wells Fargo Healthcare Conference


Annexon Quarterly report: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Annexon Quarterly report: Q2 2024


Annexon Earnings release: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Annexon Earnings release: Q2 2024


Annexon Registration statement: Registration Filing

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Annexon Registration statement: Registration Filing


Annexon Announces Proposed Public Offering of Common Stock

Jun 4, 2024, 5:06 PM EDT - 2 years ago

Annexon Announces Proposed Public Offering of Common Stock


Annexon Transcript: Study Update

Jun 4, 2024, 8:30 AM EDT - 2 years ago

Annexon Transcript: Study Update


Annexon Press release: Study Update

Jun 4, 2024, 8:30 AM EDT - 2 years ago

Annexon Press release: Study Update


Annexon Slides: Study Update

Jun 4, 2024, 8:30 AM EDT - 2 years ago

Annexon Slides: Study Update


Annexon Transcript: BofA Securities 2024 Health Care Conference

May 14, 2024, 11:40 AM EDT - 2 years ago

Annexon Transcript: BofA Securities 2024 Health Care Conference


Annexon Quarterly report: Q1 2024

May 13, 2024, 4:00 PM EDT - 2 years ago

Annexon Quarterly report: Q1 2024


Annexon Earnings release: Q1 2024

May 13, 2024, 4:00 PM EDT - 2 years ago

Annexon Earnings release: Q1 2024


Annexon Slides: Q1 2024

May 13, 2024, 4:00 PM EDT - 2 years ago

Annexon Slides: Q1 2024


Annexon Proxy statement: Proxy Filing

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Annexon Proxy statement: Proxy Filing


Annexon Proxy statement: Proxy Filing

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Annexon Proxy statement: Proxy Filing


Lightening_strikes
Lightening_strikes Jul. 1 at 3:42 PM
$ANNX lolz What a POS
0 · Reply
Lightening_strikes
Lightening_strikes Jul. 1 at 3:16 PM
$ANNX junk can’t hold
0 · Reply
NewBee13
NewBee13 Jul. 1 at 1:58 PM
$ANNX Top contain broken. Will be going into the 6s. Nice
1 · Reply
makingdoughfromoptions
makingdoughfromoptions Jul. 1 at 1:56 PM
$ANNX The ol market makers having their fun with share price today out the gate. Never, ever buy before 10-10:30. That said, our catalysts await.
0 · Reply
Lightening_strikes
Lightening_strikes Jun. 30 at 12:19 PM
$ANNX there was a GBs presentation in Europe yesterday. Any insights?
0 · Reply
Lightening_strikes
Lightening_strikes Jun. 29 at 11:34 PM
$ANNX guy with 19k shares blocked me, lolz I have multiples of that!
0 · Reply
Sly15
Sly15 Jun. 29 at 2:54 PM
$ANNX Looks like they are re tooling leadership team a bit. Given their execution history I take this as a positive
1 · Reply
Akascottie
Akascottie Jun. 29 at 1:09 PM
$ANNX added to the Russell:)))
2 · Reply
makingdoughfromoptions
makingdoughfromoptions Jun. 29 at 12:24 PM
$ANNX All: Heavy institutional buying, heavy insider buying. The retail float is 15% or so of avail. shares. I suggest we follow these guys, especially when a director who runs a successful biotech investment company backs up the truck on shares. Buy, sit a spell, wait for catalysts. They are coming and ANNX will reprice massively to the better. I own or control via options 19,000 shares.
1 · Reply
NewBee13
NewBee13 Jun. 28 at 12:35 PM
$ANNX Chart hsitory says rejection at 5.60-5.70. A break through would be encouraging for growth. Rejection is just another predictable pattern. Lets see Monday!
2 · Reply
makingdoughfromoptions
makingdoughfromoptions Jun. 27 at 3:49 AM
$ANNX A probable institutional buy, shares purchased and held bu market makers and one big order sewn together. 14 million shares today. So I think I will just hang onto mine. Good things a coming.
0 · Reply
PharmaGodStock
PharmaGodStock Jun. 27 at 12:55 AM
$ANNX told u 🫶🏼😂
0 · Reply
Thomas105
Thomas105 Jun. 26 at 9:05 PM
$ANNX 6x volume than average. Can someone solve this?
2 · Reply
Lightening_strikes
Lightening_strikes Jun. 26 at 6:41 PM
$ANNX so stock trades at a 50% discount to GBS value. Gives zero to GA and 1502, let alone HUNTINGTONS why?
0 · Reply
Biotech80
Biotech80 Jun. 26 at 12:30 PM
$ANNX Charts looking good, let’s go 🤑
0 · Reply
Lightening_strikes
Lightening_strikes Jun. 24 at 10:21 PM
$ANNX forward study? Nondilutive financing? Where are they? This is NOT just GA, which is a coin toss! Can anyone prove otherwise???
0 · Reply
PharmaGodStock
PharmaGodStock Jun. 23 at 6:12 PM
$ANNX Please keep shorting we need more liquidity to 2024 highs
0 · Reply
NewBee13
NewBee13 Jun. 23 at 2:12 PM
0 · Reply
Lightening_strikes
Lightening_strikes Jun. 23 at 11:50 AM
$ANNX forward study Non dilutive financing. Where are they?
0 · Reply
NewBee13
NewBee13 Jun. 22 at 6:23 PM
$ANNX Resistance at 5.20. Punch through and next level is 5.60.
1 · Reply
Lightening_strikes
Lightening_strikes Jun. 21 at 11:19 PM
$ANNX why would people buy a stock now with data expected in November? I’m dumb
1 · Reply
Lightening_strikes
Lightening_strikes Jun. 21 at 10:55 PM
$ANNX futures down. Odds this POS down too. ? 100.%
1 · Reply